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INTRODUCTION
Prelabor rupture of membranes (PROM) at term occurs in 10% 
births, preterm prelabor rupture of membranes (PPROM) in 
2-3.5% births.[1-3] Rapid diagnosis, appropriate management 
are essential for best pregnancy outcome.[4,5] Therefore, 
timely, accurate diagnosis is essential.
Three commonly used methods for confirming rupture of 
membranes (ROM) are obvious leakage of fluid from the 
cervix, positive nitrazine test, and ferning. Sonography may 
be used to confirm oligohydramnios, but is not confirmatory 
of ROM. Neither of these tests have been found to be 100% 
sensitive or specific. Despite the significant advances in 
technology, diagnosis of ROM still requires integration of 
symptomatology, physical examination, laboratory testing.
The present study was done to determine the sensitivity 
and specificity of the AmniSure rapid immunoassay for the 
detection of true PROM and PPROM.
SUBJECTS AND METHODS
The study was carried out in women presenting with ROM 
to the labor room of a referral rural medical institute in 
Central India after approval from Ethical Committee. A total 
of 200 consecutive pregnant women who had reported with 
complaints of watery vaginal discharge, during the study 
period of around 1 year were enrolled in the study. Patients 
included in this study were between 18 and 44 years of age 
and ≥28 and ≤42 weeks of gestation. They had symptoms 
suggestive of PROM and gave consent to participate.
Women who had fetal genitourinary/renal anomalies, placenta 
previa or had a digital vaginal examination performed prior to 
evaluation for PROM, or who had active labor, were excluded.
Original Article






Address for correspondence 
Prof. Shakuntala Chhabra, 
Department of Obstetrics and Gynecology, Mahatma Gandhi Institute 
of Medical Sciences, Sewagram, Wardha ‑ 442 102, Maharashtra, India. 
E‑mail: chhabra_s@rediffmail.com
A B S T R A C T
Background: Accurate, early diagnosis, prompt appropriate intervention is essential in the management of rupture of 
membranes (ROM), especially preterm. Aim: The aim was to determine efficacy of AmniSure rapid immunoassay placental 
alpha‑microglobulin‑1 test for accurate diagnosis of true ROM in women with watery discharge after 28 weeks gestation, 
compare with conventional methods. Subjects and Methods: Study was carried out in women presenting with ROM to labor 
the room of referral rural medical institute in Central India after ethical approval. Prospective study was performed in women 
presenting with symptoms/signs of ROM after 28 weeks of gestation. Sterile speculum examination was performed to observe 
pooling of liquor. Nitrazine, ferning tests were done to diagnose ROM. Vaginal examination was performed to determine cervical 
dilatation, effacement, station of presenting part in term cases. If all or 2 of 3 tests (pooling, ferning, and nitrazine) were positive, 
provisional diagnosis of ROM was made. Confirmation of ROM was done at birth. However, if 2 of 3 tests were negative, sterile 
speculum examination was repeated after 30 min of the first test. Test performance was calculated by comparing AmniSure 
results against final diagnosis at birth. Of 200 patients between 28 and 42 weeks gestation recruited for study, 31.5% (63/200) 
were preterm, 68.5% (137/200) term. Statistical analysis of data collected in the electronic database using SPSS version (Amnisure 
International LLC, 30 JFK Street, 4th Floor, Cambridge, MA 02138, USA). Results: AmniSure rapid immunoassay, rapid method for 
diagnosis of ROM, has 100% specificity, 99.44% sensitivity (one false negative due to meconium and immediate cesarean section). 
Conclusion: In comparison to nitrazine, pooling, ferning, AmniSure has almost 100% sensitivity, specificity.
KEY WORDS: AmniSure, diagnosis, meconium, preterm, term rupture of membranes
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An informed written consent was taken for each case. After a 
thorough history and clinical examination to exclude patients 
with vaginal bleeding, a blind vaginal swab was placed in the 
vagina for 1 min, and then dipped for 1 min in the solvent vial 
provided with the AmniSure test kit (AmniSure International 
LLC, Boston, MA, USA). The sample was then stored to be 
evaluated by the research assistant, who was blinded to the 
findings of the clinical examination. The AmniSure strip was 
dipped in the solvent for 5 min, and the result was observed 
and interpreted. The presence of two lines indicated a positive 
result, while a single line indicated a negative result. Sterile 
speculum examination was performed to observe pooling of 
liquor, collect specimens for the nitrazine and ferning tests. 
Sterile vaginal examination was then performed in term cases 
to determine cervical dilatation, effacement, and station of 
the presenting part. If all or at least, 2 out of the 3 traditional 
tests (i.e. pooling, ferning, and nitrazine) were positive, 
the membranes were considered to be clinically ruptured. 
However, if 2 out of 3 tests were negative, then a speculum 
examination was done with aseptic precautions, 30 min 
after the first, to allow the nitrazine, pooling, and ferning 
tests to be run again. Final test performance was calculated 
by comparing the results of the AmniSure test against final 
diagnosis at birth and the results of other tests performed 
during the evaluation.
An obstetric ultrasonography (USG) was performed for 
gestation, presentation, congenital anomalies, and amniotic 
fluid index (AFI). USG revealing oligoamnios further suggested 
ROM. The management protocol for confirmed PROM was 
followed. All the results were documented in the data sheets 
used for analysis. Statistical analysis of data collected the 
electronic database was done using SPSS version.
RESULTS
Of 200 women, two were younger than 20 years of age, 
115 between 20 and 24 years, 62 between 25 and 29 years, 
16 between 30 and 34 years and five were 35 years or 
above. A total of 120 women were primigravida, 47 second 
gravida, 20 third gravida, 9 fourth gravida, and 4 were fifth 
gravida. Twenty-four women had gestation between 28 
and 32 weeks, 39 between 33 and 36 weeks (63 preterm), 
119 between 37 and 40 weeks, and 18 between 40 and 
42 weeks (137 term). Of 63 women with preterm gestation, 
54 (85.72%) were diagnosed to be having ROM and 
9 (14.28%) no ROM. Of the 137 women with term gestation, 
127 (92.70%), had ROM, but 10 (7.29%) did not. Overall, 
181 (90.5%) were diagnosed to have ROM and 19 (9.5%) no 
ROM at initial evaluation [Table 1].
In 19 cases, the AmniSure test was negative, in 180 cases, 
it was positive and in one case, the liquor had a lot of 
meconium, the woman had to undergo an emergency 
cesarean section, so second speculum examination (as per 
the protocol in cases of an initial negative result) could not 
be done for this case. This patient was deemed to have 
a false negative result by the AmniSure test. Ideally for 
false negative, repeat test should have been done. Pooling 
was positive in 177 cases, nitrazine test in 173 cases, and 
ferning in 178 cases. Hence, in comparison to AmniSure test 
which had 100% specificity and 99.44% sensitivity due to 
incomplete evaluation, nitrazine test had 95.58% sensitivity 
and 100% specificity, Pooling has 97.79% sensitivity and 
100% specificity, whereas ferning has 98.34% sensitivity and 
100% specificity.
At the time of admission, the majority of women complained 
of leaking for more than 24 h prior to their visit, and AFI 
was typically between 6 and 8 cm. Some patients reported 
leakage for <6 h prior to presentation, and the AFI was 
either <3 cm or between 3 and 5 cm [Table 2].
Of 181 women with confirmed ROM, 45 had a cesarean 
section, 39 of which were directly related to ROM, the 
remaining 6 were done for other reasons. Of 19 women with 
no ROM, 8 underwent cesarean section for various reasons. 
Overall 39 cesarean sections were done in women with 
term pregnancy and 14 in women with preterm gestation.
Overall, of the 181 women who had ROM, 1 had intrauterine 
death, 1 had stillbirth, 3 babies had neonatal death, and 
20 (11.04%) babies were admitted to the neonatal intensive 
care unit (NICU). Of the 19 babies of women who had no 
ROM, 9 (47.36%) were admitted to the NICU. In total, there 
Table 1: Age, parity, and gestation
Age 
(years)
Parity Gestation (weeks) Gestation (weeks) Total
Preterm with ROM Term with ROM Preterm without ROM Term without ROM
28-32 33 to <37 >37 to 40 >40 to <42 28-32 33 to <37 >37 to 40 >40 to <42
≤19 Primi 01 01
Multi 01 01
20-29 Primi 08 18 69 09 01 05 03 01 114
Multi 08 11 31 04 03 04 02 63
>30 Primi 05 05
Multi 07 02 05 02 16
Total 23 31 112 15 01 08 07 03 200
ROM – Rupture of membranes
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were six perinatal deaths (3.09%). The causes of deaths 
included small for gestational age, low birth weight, sepsis, 
severe birth asphyxia, respiratory distress and hydrops 
fetalis, the perinatal deaths possibly linked to ROM were 
five.
Overall of 200 cases in whom AmniSure test was performed, 
180 were true positive, 19 were true negatives, 1 was a 
false negative, as repeat testing was not done. There was 
no false positive. Accordingly, the AmniSure test had 100% 
specificity and almost 100% sensitivity also. In one case in 
which the test was false negative, the liquor had a lot of 
meconium and on account of emergency cesarean section; 
a second AmniSure test could not be done, so ideally no 
comments can be made about only one false negative.
DISCUSSION
Rupture of membrane is largely a clinical diagnosis. It is 
typically suggested by history of watery vaginal discharge on 
sterile speculum examination. The traditional diagnosis of 
ROM is by clinician’s ability to document three clinical signs 
on sterile speculum examination: (1) Visual pooling of clear 
fluid in posterior fornix of vagina or leakage of fluid from 
cervical os; (2) an alkaline pH of cervicovaginal discharge, 
demonstrated by nitrazine test; and/or (3) ferning of 
cervicovaginal discharge on drying. Moreover, sensitivity and 
specificity of the nitrazine test has been reported at 90-97% 
and 16-70%, respectively.[6-10] In the present study also, it was 
found that the nitrazine test had 95.58% sensitivity and 100% 
specificity, pooling has 97.79% sensitivity and 100% specificity, 
ferning has 98.34% sensitivity and 100% specificity. Further, the 
use of all three tests is not mandatory for diagnosis of ROM, 
when 2 of 3 are positive, clinical correlation is exercised. 
Amnio-dye infusion is the only procedure that provides a 
100% accurate result. After amniocentesis, a dye (Evans Blue 
or fluorescein) is injected into the amniotic cavity, and if a 
tampon placed in the vagina is stained blue following the 
procedure, ROM is confirmed unequivocally. However, this 
procedure is invasive, expensive, and is associated with risk 
to the pregnancy, including bleeding, infection, iatrogenic 
ROM, and possibly, loss of pregnancy (approximately 1 in 
270).[11,12] Hence, this procedure is not used in day to day 
practice. Evidence of diminished amniotic fluid volume (by 
Leopold’s examination or ultrasound) alone cannot confirm 
the diagnosis,[3] but may help in the clinical setting. With 
the possible exception of direct visualization of amniotic 
fluid spurting from cervical os, all of these clinical signs have 
limitations in terms of diagnostic accuracy, cost, and technical 
ease. Moreover, such tests become progressively less 
accurate when more than 1 h has elapsed after membranes 
have ruptured or in certain nonobvious circumstances, 
where fluid may not be present in vagina for evaluation or 
what is present may be contaminated with urine, cervical 
mucus, vaginal discharge, blood, or meconium. Because of 
these difficult situations, multiple cytological, biochemical, 
colorimetric, and sonographic methods have been proposed 
for detection of ROM, however, no one test has been found 
to be completely accurate and diagnosis often requires an 
integration of historic factors, physical examination, and 
laboratory testing.
Many trials aimed at finding more accurate ways to detect 
ROM in nonobvious cases have evaluated biochemical 
markers including those based on the detection of fetal 
fibronectin,[13,14] alpha feto protein,[15] β-human chorionic 
gonadotropin in cervicovaginal secretions,[16] and 
insulin-like growth factor binding protein (IGFBP).[15,17] None 
of these markers, however, have proven to be reliable 
means to accurately diagnose true ROM. A recent study has 
revealed that IGFBP-1 is also an effective method with high 
sensitivity and specificity for the diagnosis of PROM.[18] To 
the contrary, investigators have demonstrated an excellent 
performance for test based on detection of placental alpha 
microglobulin-1 (PAMG-1), a rapid 5 min noninstrumented 
qualitative immunochromatographic test cleared by the FDA 
in 2004 (AmniSure ROM test, AmniSure International LLC, 
Boston, MA, USA). The test employs monoclonal antibodies, 
detects even a miniscule amount of PAMG-1, which is 
found in high concentrations in cervicovaginal secretions 
after ROM has occurred. AmniSure is believed to be highly 
accurate (over 99% sensitivity) and is easy to use.[19-26]
In the present study, 200 women who had presented with 
watery discharge, but did not have obvious membranes 
ruptured were evaluated for ROM by AmniSure test. Finally, 
the diagnosis of ROM was determined at birth. Overall, 
200 cases available for analysis, the AmniSure test was 






<3 3-5 6-8 9-11 >11
28-32 No leaking 01 01
<6 00
6-12 02 03 15 20
12-24 00
>24 01 02 03
33≤37 No leaking 03 05 08
<6 01 01
6-12 01 01 02
12-24 01 02 02 05
>24 14 06 03 23
>37-40 No leaking 02 05 07
<6 02 01 03
6-12 01 08 08 01 18
12-24 01 26 16 02 45
>24 01 24 17 04 46
>40 No leaking 02 01 03
<6 00
6-12 01 01
12-24 01 05 01 07
>24 05 02 07
Total 03 03 85 70 39 200
AFI – Amniotic fluid index
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positive in 180 of these, 19 were true negatives, 1 was false 
negative and there was no false positive. Accordingly, the 
AmniSure test had 99.44% sensitivity, though with problem 
of loss of the second test and 100% specificity.
The study revealed excellent accuracy of the AmniSure test 
in the Indian population presenting with watery vaginal 
discharge. In comparison to nitrazine, pooling, and the 
ferning tests, the AmniSure test had better sensitivity and 
specificity.
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